Cambridge Laboratories, Valeant sales and marketing update

VRX acquired rights to market Cambridge Laboratories' nabilone in the U.K. and other undisclosed European countries to treat chemotherapy-induced nausea and vomiting (CINV). VRX markets the cannabinoi...